Type 2 diabetes mellitus and fracture risk.

作者: Anastasia D. Dede , Symeon Tournis , Ismene Dontas , George Trovas

DOI: 10.1016/J.METABOL.2014.09.002

关键词:

摘要: Increased fracture risk, traditionally associated with type 1 diabetes, has lately been of great concern in patients 2 diabetes. A variable increase risk reported, ranging from 20% to 3-fold, depending on skeletal site, diabetes duration and study design. Longer disease duration, the presence diabetic complications, inadequate glycemic control, insulin use increased for falls are all reported risk. Patients display a unique phenotype either normal or more frequently increased, bone mineral density impaired structural geometric properties. Recently, alterations material properties seem be predominant defect leading fragility. Accumulation advanced glycation end-products changes collagen cross-linking along suppression turnover significant factors impairing strength. FRAX score underestimate lumbar spine BMD is predicting vertebral fractures. Anti-diabetic medications, apart thiazolidinediones, appear safe skeleton, although data needed. Optimal strategies reduce fragility yet determined.

参考文章(105)
Dennis B Henriksen, Peter Alexandersen, Bolette Hartmann, Charlotte L Adrian, Inger Byrjalsen, Henry G Bone, Jens J Holst, Claus Christiansen, None, Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women. Bone. ,vol. 40, pp. 723- 729 ,(2007) , 10.1016/J.BONE.2006.09.025
Ann V Schwartz, Anne L Schafer, Andrew Grey, Eric Vittinghoff, Lisa Palermo, Li-Yung L Lui, Robert B Wallace, Steven R Cummings, Dennis M Black, Douglas C Bauer, Ian R Reid, Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. Journal of Bone and Mineral Research. ,vol. 28, pp. 1348- 1354 ,(2013) , 10.1002/JBMR.1865
Roberto J Fajardo, Lamya Karim, Virginia I Calley, Mary L Bouxsein, A Review of Rodent Models of Type 2 Diabetic Skeletal Fragility Journal of Bone and Mineral Research. ,vol. 29, pp. 1025- 1040 ,(2014) , 10.1002/JBMR.2210
G. Mabilleau, A. Mieczkowska, M. E. Edmonds, Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression Diabetic Medicine. ,vol. 27, pp. 925- 932 ,(2010) , 10.1111/J.1464-5491.2010.03048.X
M. Retzepi, N. Donos, The effect of diabetes mellitus on osseous healing Clinical Oral Implants Research. ,vol. 21, pp. 673- 681 ,(2010) , 10.1111/J.1600-0501.2010.01923.X
Roberta Sanguineti, Daniela Storace, Fiammetta Monacelli, Alberto Federici, Patrizio Odetti, Pentosidine effects on human osteoblasts in vitro. Annals of the New York Academy of Sciences. ,vol. 1126, pp. 166- 172 ,(2008) , 10.1196/ANNALS.1433.044
A. Shu, M. T. Yin, E. Stein, S. Cremers, E. Dworakowski, R. Ives, M. R. Rubin, Bone structure and turnover in type 2 diabetes mellitus Osteoporosis International. ,vol. 23, pp. 635- 641 ,(2012) , 10.1007/S00198-011-1595-0
R. Dhaliwal, D. Cibula, C. Ghosh, R. S. Weinstock, A. M. Moses, Bone quality assessment in type 2 diabetes mellitus. Osteoporosis International. ,vol. 25, pp. 1969- 1973 ,(2014) , 10.1007/S00198-014-2704-7
Qi-Guang Mai, Zhong-Min Zhang, Song Xu, Ming Lu, Rong-Ping Zhou, Li Zhao, Chun-Hong Jia, Zhi-Hua Wen, Da-Di Jin, Xiao-Chun Bai, Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. Journal of Cellular Biochemistry. ,vol. 112, pp. 2902- 2909 ,(2011) , 10.1002/JCB.23206